Previous studies together with our findings imply that, for one thing, MDM2 may inhibit the activity of tumor suppressor proteins (such as p53) in tumor cells; for another, it may enhance the immunosuppressive capacity of Treg cells in tumor microenvironment, thus jointly facilitating the progression of tumors. The gene discussed is TCHP; the disease is neoplasm.